Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Neuronetics, Inc. logo — Non-drug, safe, effective treatment for depression and other...

Neuronetics, Inc.

Non-drug, safe, effective treatment for depression and other mental health conditions.

Founded 2003 United States Malvern, United States 220 employees Post-IPO Debt Total: $373.40M Biotechnology, Health Care +3

General Information

Company Name Neuronetics, Inc.
Founded Year 2003
Location United States Malvern, United States
Founders / Decision Makers
Team member
Employees 220
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Neuronetics, Inc.. To contact Neuronetics, Inc., visit neurostar.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neuronetics, Inc. compare?

A PDF of Neuronetics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neuronetics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neuronetics, Inc.

Neuronetics, Inc. is a U.S.-based public medical device company specializing in non-drug, safe, and effective treatments for depression and other mental health conditions. Established in 2003, Neuronetics is the innovator behind NeuroStar Advanced Therapy, the leading Transcranial Magnetic Stimulation (TMS) solution for Major Depressive Disorder and other mental health issues. The company's strategic vision revolves around revolutionizing patient care with top-tier neurohealth therapies. NeuroStar has set itself apart as the leading TMS choice among physicians, with over 6.4 million treatments administered. Notably, it is a non-invasive, outpatient treatment that takes as little as 20 minutes per session for 36 sessions, promoting neuroplasticity to target mental health at its core—the brain. Neuronetics markets NeuroStar Advanced Therapy in the U.S. and several global markets, positioning itself as a key player in the Biotechnology, Health Care, and Manufacturing industries. In a recent funding development, Neuronetics secured a notable $60.00M Post-IPO Debt investment on April 4, 2023, with SLR Capital Partners participating as the investor. This investment underlines the confidence in Neuronetics' approach and potentially signifies a significant growth phase for the company.

Business keywords: TMS Therapy, Neuropsychiatric Treatment, Non-invasive Therapy, Mental Health, Medical Device, Neurological Disorders, Transcranial Magnetic Stimulation, Neuroplasticity, Depression Treatment, Outpatient Treatment, Medical Technology, MRI-Strength Magnetic Field Pulses, Psychiatric Disorders, Neurohealth Therapies, Neuronetics

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $60.00M 1
SLR Capital Partners
04 Apr 2023
Post IPO Equity Undisclosed 1
J Carlo Cannell
27 Jun 2022
Post IPO Equity $80.60M -
02 Feb 2021
Post IPO Debt $15.00M 1
Solar capital
20 Dec 2020
Debt Financing $50.00M -
01 Jan 2020
Series G $15.00M 10
GE Ventures Industry Ventures InterWest Partners
GE Ventures, Industry Ventures +8
06 Jun 2017
Series F $34.30M 9
GE Ventures New Leaf Venture Partners Polaris Partners
GE Ventures, New Leaf Venture Partners +7
27 Apr 2015
Series E $30.00M 8
InterWest Partners New Leaf Venture Partners Polaris Partners
InterWest Partners, New Leaf Venture Partners +6
16 May 2011
Series D $30.00M 8
InterWest Partners New Leaf Venture Partners Onset Ventures
InterWest Partners, New Leaf Venture Partners +6
27 Oct 2009
Series C $35.00M 6
InterWest Partners Onset Ventures Investor Growth Capital
InterWest Partners, Onset Ventures +4
17 Aug 2006

View All 12 Funding Rounds

Neuronetics, Inc. Alternatives & Competitors

View All Alternatives
Neuronetics, Inc. vs
Modalis TMS
Modalis TMS Australia

WA's trusted name in using Transcranial Magnetic Stimulation (TMS) to treat depression & more | Pert...

15 employees
Health Care, Health and Wellness
Neuronetics, Inc. vs
Salience TMS Neuro Solutions, LLC
Salience TMS Neuro Solutions, LLC United States

Every Connection Matters. Don't Let Depression Separate You From What's Important.

78 employees
Health Care, Health and Wellness
Neuronetics, Inc. vs
Nexstim
Nexstim Finland

We enable personalized and effective therapies and diagnostics for challenging brain diseases and di...

Post-IPO Debt
52 employees
Biotechnology, Health Care
Compare Neuronetics, Inc. vs Nexstim
Also compare with: Neuronetics, Inc. vs Heading Health Heading Health View all alternatives

FAQ About Neuronetics, Inc.

Non-drug, safe, effective treatment for depression and other mental health conditions.
Neuronetics, Inc. was founded in 2003.
Neuronetics, Inc. is headquartered in Malvern, United States.
Neuronetics, Inc. operates in Biotechnology, Health Care, Health and Wellness, Manufacturing and Medical Devices. Its work centres on TMS Therapy, Neuropsychiatric Treatment, Non-invasive Therapy and Mental Health.
Neuronetics, Inc. has approximately 220 employees.
Neuronetics, Inc. has completed 12 funding rounds, raising a total of $373.40M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Neuronetics, Inc. include Modalis TMS, Salience TMS Neuro Solutions, LLC, Nexstim, BrainsWay, Dothan Behavioral Medicine Clinic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neuronetics, Inc. and Modalis TMS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neuronetics, Inc., https://bouncewatch.com/company/neuronetics-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes